Market Tracker

09/26 5:16pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

0.3416
Delayed Data
As of Sep 26
 -0.0081 / -2.32%
Today’s Change
0.28
Today|||52-Week Range
1.68
-65.49%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close0.35
Today’s open0.35
Day’s range0.34 - 0.37
Volume553,208
Average volume (3 months)700,059
Market cap$23.2M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+54.39%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PVCTProvectus Biopharmac...-0.00-4.40%
OPXAOpexa Therapeutics I...-0.06-1.83%
PULMPulmatrix Inc-0.08-4.91%
BLPHBellerophon Therapeu...-0.04-2.68%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, Secretary &
Director
Richard W. Pascoe
Chief Accounting Officer &
Vice President-Finance
Catherine Bovenizer
Corporate headquarters
San Diego, California

Forecasts